Literature DB >> 17360434

Cross-talk between Chk1 and Chk2 in double-mutant thymocytes.

Kathrin Zaugg1, Yu-Wen Su, Patrick T Reilly, Yasmin Moolani, Carol C Cheung, Razquallah Hakem, Atsushi Hirao, Qinghua Liu, Stephen J Elledge, Tak W Mak.   

Abstract

Chk1 is a checkpoint kinase and an important regulator of mammalian cell division. Because null mutation of Chk1 in mice is embryonic lethal, we used the Cre-loxP system and the Lck promoter to generate conditional mutant mice in which Chk1 was deleted only in the T lineage. In the absence of Chk1, the transition of CD4(-)CD8(-) double-negative (DN) thymocytes to CD4(+)CD8(+) double-positive (DP) cells was blocked due to an increase in apoptosis at the DN2 and DN3 stages. Strikingly, loss of Chk1 activated the checkpoint kinase Chk2 as well as the tumor suppressor p53 in these thymocytes. However, the developmental defects caused by Chk1 deletion were not rescued by p53 inactivation. Significantly, even though Chk1 deletion is highly lethal in proliferating tissues, we succeeded in using in vivo methods to generate Chk1/Chk2 double-knockout T cells. Analysis of these T cells revealed an interesting interaction between Chk1 and Chk2 functions that partially rescued the apoptosis of the double-mutant cells. Thus, Chk1 is both critical for the survival of proliferating cells and engages in cross-talk with the Chk2 checkpoint kinase pathway. These factors have implications for the targeting of Chk1 as an anticancer therapy.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17360434      PMCID: PMC1820665          DOI: 10.1073/pnas.0611584104

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage.

Authors:  Ronit I Yarden; Sherly Pardo-Reoyo; Magda Sgagias; Kenneth H Cowan; Lawrence C Brody
Journal:  Nat Genet       Date:  2002-02-11       Impact factor: 38.330

2.  Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of Brca1 at distinct and overlapping sites. In vivo assessment using phospho-specific antibodies.

Authors:  M Gatei; B B Zhou; K Hobson; S Scott; D Young; K K Khanna
Journal:  J Biol Chem       Date:  2001-02-13       Impact factor: 5.157

3.  Claspin, a novel protein required for the activation of Chk1 during a DNA replication checkpoint response in Xenopus egg extracts.

Authors:  A Kumagai; W G Dunphy
Journal:  Mol Cell       Date:  2000-10       Impact factor: 17.970

4.  Genes involved in DNA repair are mutational targets in endometrial cancers with microsatellite instability.

Authors:  Vessela Vassileva; Anna Millar; Laurent Briollais; William Chapman; Bharati Bapat
Journal:  Cancer Res       Date:  2002-07-15       Impact factor: 12.701

5.  Tissue- and site-specific DNA recombination in transgenic mice.

Authors:  P C Orban; D Chui; J D Marth
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

6.  Somatic mutations in the DNA damage-response genes ATR and CHK1 in sporadic stomach tumors with microsatellite instability.

Authors:  A Menoyo; H Alazzouzi; E Espín; M Armengol; H Yamamoto; S Schwartz
Journal:  Cancer Res       Date:  2001-11-01       Impact factor: 12.701

7.  Chk1 is an essential kinase that is regulated by Atr and required for the G(2)/M DNA damage checkpoint.

Authors:  Q Liu; S Guntuku; X S Cui; S Matsuoka; D Cortez; K Tamai; G Luo; S Carattini-Rivera; F DeMayo; A Bradley; L A Donehower; S J Elledge
Journal:  Genes Dev       Date:  2000-06-15       Impact factor: 11.361

8.  Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress.

Authors:  R S Tibbetts; D Cortez; K M Brumbaugh; R Scully; D Livingston; S J Elledge; R T Abraham
Journal:  Genes Dev       Date:  2000-12-01       Impact factor: 11.361

9.  Disruption of the checkpoint kinase 1/cell division cycle 25A pathway abrogates ionizing radiation-induced S and G2 checkpoints.

Authors:  Hui Zhao; Janis L Watkins; Helen Piwnica-Worms
Journal:  Proc Natl Acad Sci U S A       Date:  2002-10-24       Impact factor: 11.205

10.  Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner.

Authors:  Atsushi Hirao; Alison Cheung; Gordon Duncan; Pierre-Marie Girard; Andrew J Elia; Andrew Wakeham; Hitoshi Okada; Talin Sarkissian; Jorge A Wong; Takashi Sakai; Elisa De Stanchina; Robert G Bristow; Toshio Suda; Scott W Lowe; Penny A Jeggo; Stephen J Elledge; Tak W Mak
Journal:  Mol Cell Biol       Date:  2002-09       Impact factor: 4.272

View more
  29 in total

1.  Acidic nuclear phosphoprotein 32kDa (ANP32)B-deficient mouse reveals a hierarchy of ANP32 importance in mammalian development.

Authors:  Patrick T Reilly; Samia Afzal; Chiara Gorrini; Koren Lui; Yury V Bukhman; Andrew Wakeham; Jillian Haight; Teo Wei Ling; Carol C Cheung; Andrew J Elia; Patricia V Turner; Tak Wah Mak
Journal:  Proc Natl Acad Sci U S A       Date:  2011-06-02       Impact factor: 11.205

2.  Lineage extrinsic and intrinsic control of immunoregulatory cell numbers by SHIP.

Authors:  Michelle M Collazo; Kim H T Paraiso; Mi-Young Park; Amy L Hazen; William G Kerr
Journal:  Eur J Immunol       Date:  2012-07       Impact factor: 5.532

3.  Co-abrogation of Chk1 and Chk2 by potent oncolytic adenovirus potentiates the antitumor efficacy of cisplatin or irradiation.

Authors:  F Ye; Z Yang; Y Liu; D Gong; T Ji; J Wang; B Xi; J Zhou; D Ma; Q Gao
Journal:  Cancer Gene Ther       Date:  2014-05-23       Impact factor: 5.987

4.  The DNA damage effector Chk1 kinase regulates Cdc14B nucleolar shuttling during cell cycle progression.

Authors:  Sirisha Peddibhotla; Zhubo Wei; Rao Papineni; Micheal H Lam; Jeffrey M Rosen; Pumin Zhang
Journal:  Cell Cycle       Date:  2011-02-15       Impact factor: 4.534

5.  Role of Chk1 in the differentiation program of hematopoietic stem cells.

Authors:  Laura Carrassa; Elisa Montelatici; Lorenza Lazzari; Stefano Zangrossi; Matteo Simone; Massimo Broggini; Giovanna Damia
Journal:  Cell Mol Life Sci       Date:  2010-02-10       Impact factor: 9.261

6.  CRL4(CDT2) targets CHK1 for PCNA-independent destruction.

Authors:  Jiwon Huh; Helen Piwnica-Worms
Journal:  Mol Cell Biol       Date:  2012-10-29       Impact factor: 4.272

7.  Checkpoint kinase 1 (Chk1)-short is a splice variant and endogenous inhibitor of Chk1 that regulates cell cycle and DNA damage checkpoints.

Authors:  Navjotsingh Pabla; Kirti Bhatt; Zheng Dong
Journal:  Proc Natl Acad Sci U S A       Date:  2011-12-19       Impact factor: 11.205

Review 8.  Roles of Chk1 in cell biology and cancer therapy.

Authors:  Youwei Zhang; Tony Hunter
Journal:  Int J Cancer       Date:  2013-05-28       Impact factor: 7.396

9.  Bmi1 regulates mitochondrial function and the DNA damage response pathway.

Authors:  Jie Liu; Liu Cao; Jichun Chen; Shiwei Song; In Hye Lee; Celia Quijano; Hongjun Liu; Keyvan Keyvanfar; Haoqian Chen; Long-Yue Cao; Bong-Hyun Ahn; Neil G Kumar; Ilsa I Rovira; Xiao-Ling Xu; Maarten van Lohuizen; Noboru Motoyama; Chu-Xia Deng; Toren Finkel
Journal:  Nature       Date:  2009-04-29       Impact factor: 49.962

10.  Chk1 haploinsufficiency results in anemia and defective erythropoiesis.

Authors:  Nathan C Boles; Sirisha Peddibhotla; Alice J Chen; Margaret A Goodell; Jeffrey M Rosen
Journal:  PLoS One       Date:  2010-01-05       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.